Cameron Turtle
Chief executive of Spire Therapeutics (a Paragon/Fairmount spin-out) leading development of long-acting biologics and combination therapies for inflammatory bowel disease.
Best podcasts with Cameron Turtle
Ranked by the Snipd community
25 snips
Mar 5, 2026 • 30min
391: Breaching the IBD efficacy ceiling, and sham surgeries
Cameron Turtle, CEO of Spire Therapeutics and builder of long-acting biologics and combination IBD therapies, discusses strategies to surpass the IBD efficacy ceiling. He explains why co-formulated combinations and replacing older mechanisms could boost remission rates. The conversation also touches on regulatory debates around rare-disease approvals and sham-surgery ethics.
